ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2026
Habitual tea consumption and survival in laryngeal squamous cell carcinoma: a single-center retrospective cohort (2021-2024).
Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo examine whether habitual tea consumption is associated with survival and early postoperative complications among patients with laryngeal squamous cell carcinoma (LSCC) [1-4].
methodsSingle-center retrospective cohort (2021-2024). Adults with primary LSCC treated with curative intent were included (N = 108). EXPOSURE: regular tea (≥ 3 times/week for ≥ 6 months; n = 73) vs. non-regular (n = 35). PRIMARY ENDPOINTS: overall survival (OS) and recurrence-free survival (RFS) by Kaplan-Meier with log-rank tests; multivariable Cox adjusted for age, sex, T/N category, overall stage, treatment modality, smoking (pack-years), alcohol use, and Charlson Comorbidity Index (CCI). Median follow-up 23.0 months (interquartile range [IQR] 17.1-32.3).
resultsTwo-year RFS was higher in regular tea drinkers than in non-regular drinkers (83.8% vs. 45.8%; log-rank p = 0.0043); two-year OS was similar (72.4% vs. 75.4%; p = 0.5651). Early complications were lower among tea drinkers: 30-day infection 6.8% vs. 20.0% (p = 0.0418) and borderline 90-day dysphagia 4.1% vs. 17.1% (p = 0.0556). Findings were directionally consistent in adjusted analyses.
conclusionsHabitual tea consumption was associated with higher RFS and fewer early infections after curative-intent therapy for LSCC, whereas OS did not differ. Results indicate association rather than causation and warrant prospective validation.
Indexed as
Identifiers
41288697What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.